A detailed history of Cutler Group LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cutler Group LP holds 100 shares of TMDX stock, worth $6,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$6,881
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$53.47 - $96.07 $37,429 - $67,249
700 New
700 $38,000
Q1 2022

Apr 14, 2022

SELL
$12.58 - $26.94 $34,469 - $73,815
-2,740 Reduced 92.13%
234 $6,000
Q4 2021

Jan 18, 2022

SELL
$19.16 - $32.68 $69,608 - $118,726
-3,633 Reduced 54.99%
2,974 $56,000
Q3 2021

Oct 26, 2021

BUY
$25.92 - $34.51 $108,060 - $143,872
4,169 Added 171.0%
6,607 $218,000
Q2 2021

Jul 19, 2021

BUY
$21.63 - $40.07 $52,733 - $97,690
2,438 New
2,438 $80,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.19B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.